Article Text

Download PDFPDF
Effects of oral magnesium sulphate on colonic motility in patients with the irritable bowel syndrome
  1. R. F. Harvey,
  2. A. E. Read


    Magnesium sulphate, a substance known to cause release of cholecystokinin (CCK) from the small intestinal mucosa, was given by mouth (dose 0·1g/kg in 150 ml water) to 20 patients with the irritable bowel syndrome. A rapid increase in colonic segmental motor activity (onset within two to six minutes in most cases) was seen (percentage activity increased from 16·2 to 23·7 p<0·05; mean wave amplitude from 7·1 to 9·1 cm H2O, NS; motility index from 144 to 259, p<0·01). This increase was most marked in 10 patients who complained of attacks of abdominal pain after food (16·1 to 29·8%, p<0·01; 6·8 to 9·6 cm H2O, p<0·05; 135 to 350, p<0·05), and after the magnesium sulphate three of these patients experienced an attack of their usual pain. These findings provide further evidence that `functional' abdominal pain after food may in some cases be related to an exaggerated intestinal motor response to cholecystokinin.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    • 1 Based on a paper read to the British Society of Gastroenterology on 6th April 1973.